phenothiazine has been researched along with Idiopathic Parkinson Disease in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (95.83) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenamyre, JT; McCoy, JL; Tapias, V | 1 |
| DE HAAS, G | 1 |
| SEGARD, M; SIGURET, G | 1 |
| GILLHESPY, RO | 1 |
| HELD, F | 1 |
| KOEPPE, HW | 1 |
| BERRIS, H | 1 |
| DE MAAR, EW | 1 |
| ELIASSON, S; TEJNING, S | 1 |
| IVES, ER; SOBUE, I | 1 |
| DELAY, J; DENIKER, P; THUILLIER, J | 1 |
| SCHULZ, HP | 1 |
| FREYHAN, FA | 1 |
| KARN, WN; KASPER, S | 1 |
| AHMED, A; MARSHALL, PB | 1 |
| BERTINCHAMPS, A; BORG, DC; COTZIAS, GC; HUGHES, ER; PAPAVASILIOU, PS | 1 |
| TORRES, F; ZIEGLER, DK | 1 |
| CLAFFEY, B; MANDEL, W; MARGOLIS, LH | 1 |
| MANDEL, W; OLIVER, WA | 1 |
| ARNE, L; DELMAS-MARSALET, P; FAURE, J | 1 |
| ALTAMIRANO, M; SOLARI, G; UIBERALL, E | 1 |
| FOURNEL, J | 1 |
| HELLER, GC; SIME, DA | 1 |
24 other study(ies) available for phenothiazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Phenothiazine normalizes the NADH/NAD
Topics: Animals; Biomarkers; Cell Culture Techniques; Corpus Striatum; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Mitochondria; Models, Biological; NAD; Neuroprotection; Neuroprotective Agents; Parkinson Disease; Phenothiazines; Rats; Rotenone; Substantia Nigra | 2019 |
[Agranulocytosis due to diparcol].
Topics: Agranulocytosis; Antipsychotic Agents; Parkinson Disease; Phenothiazines | 1952 |
[Therapeutic diagrams].
Topics: Antipsychotic Agents; Heterocyclic Compounds; Parkinson Disease; Phenothiazines; Trihexyphenidyl | 1953 |
Lysivane in the treatment of Parkinsonism.
Topics: Antipsychotic Agents; Heterocyclic Compounds; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1953 |
[Preliminary experiences with dibutil in therapy of the Parkinson syndrome].
Topics: Antipsychotic Agents; Parkinson Disease; Phenothiazines | 1953 |
[Treatment of parkinsonism with dibutil].
Topics: Antipsychotic Agents; Heterocyclic Compounds; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1954 |
Parkinsonism: preliminary report on two new antiparkinsonian agents.
Topics: Antiparkinson Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1954 |
[Pharmacokinetics in parkinsonism].
Topics: Anticonvulsants; Antipsychotic Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Phenothiazines; Trihexyphenidyl | 1955 |
Clinical trials of transergan in the parkinsonian syndrome.
Topics: Antipsychotic Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1956 |
Parsidol in the treatment of Parkinson's syndrome.
Topics: Antipsychotic Agents; Cardiovascular Agents; Muscle Relaxants, Central; Parkinson Disease; Phenothiazines | 1956 |
[Similarity of the neurological complications of prochlorperazine with various post-encephalitic disorders].
Topics: Diagnosis, Differential; Humans; Nervous System Diseases; Parkinson Disease; Phenothiazines; Prochlorperazine; Tranquilizing Agents | 1957 |
[Treatment of parkinsonism; effect of pacatal on Parkinson's tremors].
Topics: Autonomic Agents; Parkinson Disease; Phenothiazines; Tremor | 1957 |
[Psychomotility, extrapyramidal syndrome and mode of action of neuroleptic therapies; chlorpromazine, reserpine and prochlorperazine].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Mental Disorders; Parkinson Disease; Phenothiazines; Prochlorperazine; Psychotherapy; Reserpine | 1957 |
[Use of a new neuroleptic].
Topics: Antipsychotic Agents; Parkinson Disease; Phenothiazines | 1959 |
Pharmacologically induced Parkinson-like signs as index of the therapeutic potential.
Topics: Extrapyramidal Tracts; Humans; Mental Disorders; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1959 |
Relationship between anti-acetylcholine and anti-Tremorine activity in anti-parkinsonian and related drugs.
Topics: Acetylcholine; Animals; Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Cholinergic Antagonists; Guinea Pigs; Heterocyclic Compounds; Ileum; Mice; Parkinson Disease; Phenothiazines; Tremor; Tremorine | 1962 |
Phenothiazines: curative or causative in regard to parkinsonism?
Topics: Antipsychotic Agents; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1961 |
Parsidol in the treatment of parkinsonism.
Topics: Antipsychotic Agents; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1955 |
Recurrent thioperazine-induced extrapyramidal reaction following placebo substitution for maintenance antiparkinson drug.
Topics: Antiparkinson Agents; Antipsychotic Agents; Atropine Derivatives; Extrapyramidal Tracts; Parkinson Disease; Phenothiazines; Trihexyphenidyl | 1961 |
Withdrawal of maintenance antiparkinson drug in the phenothiazine-induced extrapyramidal reaction.
Topics: Antiparkinson Agents; Conduct Disorder; Humans; Parkinson Disease; Phenothiazines; Trihexyphenidyl | 1961 |
[Myographic study on the effects of diethylamino-ethyl-N-thiodiphenylamine chlorhydrate on the hypertonia of Parkinson's disease].
Topics: Humans; Myography; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1950 |
[Mode of action of a synthetic derivative of phenothiazine having a therapeutic effect in Parkinson's disease].
Topics: Humans; Parkinson Disease; Parkinsonian Disorders; Phenothiazines | 1951 |
[Pharmacological properties of (diethylamino-28 propyl-18)-N phenothiazine. Pharmacological study of a new active compound in Parkinson disease].
Topics: Humans; Parkinson Disease; Parkinsonian Disorders; Phenothiazines; Research | 1950 |
Agranulocytosis during treatment with diethazine hydrochloride.
Topics: Agranulocytosis; Cholinergic Antagonists; Parkinson Disease; Phenothiazines | 1952 |